Advertisement

Picture BIO Deutschland Biotech Investors Day BID 2019 Würzburg iito 600x60px
Document › Details

Evolva Holding S.A.. (10/26/17). "Press Release: Evolva Announces Final Terms of Proposed Capital Increase [Not for release in US, CA, JP or AU or any jurisdiction where unlawful]".

Organisations Organisation Evolva Holding SA (SIX: EVE)
  Group Evolva (Group)
  Organisation 2 Pictet Asset Management S.A.
  Group Pictet (Group)
Products Product industrial biotechnology
  Product 2 investment banking
Index terms Index term Evolva–SEVERAL: investment, 201710 capital increase CHF21.1m private placement to Pictet Asset Management + Cologny Advisors at CHF0.31/share
  Index term 2 Evolva–SEVERAL: investment, 201710 capital increase CHF65m discounted right offering
Persons Person Walker, Oliver (Evolva 201807– CEO before CFO before Sivantos + Nobel Biocare + Sonova + Stratec)
  Person 2 Verbraeken, Paul (Evolva 201105 Investor Relations Manager)
     


   
Record changed: 2017-11-03

Advertisement

Picture BIO Deutschland Biotech Investors Day BID 2019 Würzburg iito 600x60px

More documents for Evolva (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px




» top